Clinical trial No longer in our active list Interventional Ages 0 Weeks to 18 Weeks

Evaluating treatment duration for stable Graf IIc hips in children

Official title: How Should Stable Graf Type IIc Hips be Treated With Pavlik Harness?

Run by University of Colorado, Denver · NCT03275805 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a shorter or standard 12-week treatment with a Pavlik Harness is better for babies with stable Graf type IIc hips who have Developmental Dysplasia of the Hip.

Quick facts

Study typeInterventional
Ages0 Weeks to 18 Weeks
SexAll
Enrollment100 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Locations1 site (Aurora, Colorado)
Trial IDNCT03275805 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are infants aged 0-18 weeks diagnosed with stable Graf type IIc hips and presenting with an abnormal ultrasound.

Probably not a fit

Patients with unstable hips or additional neurologic or teratologic conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the optimal duration of Pavlik Harness treatment for children diagnosed with Developmental Dysplasia of the Hip (DDH) who have stable Graf type IIc hips. Participants aged 0-18 weeks will be randomly assigned to receive either the standard 12-week treatment or a shorter duration based on normalization of their hip condition. The study aims to determine the most effective treatment length by analyzing follow-up radiographs at two years. This research addresses a gap in current orthopedic practices regarding the management of stable Graf IIc hips.

Why it matters

Potential benefit: If successful, this study could provide clearer guidelines for treating children with stable Graf IIc hips, potentially improving treatment outcomes.

How similar studies have gone: While Pavlik Harness treatment is well-established, this specific investigation into the duration for Graf IIc hips is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with:

* DDH
* Graf IIc hips (alpha angle = 43-49 degrees)
* normal hip exam (stable hips)
* abnormal ultrasound

Exclusion Criteria:

1. Patients with additional conditions: Neurologic or teratologic.
2. Follow up that occurs at any other institution.
3. Unstable hips

Where it's running

  • Children's Hospital Colorado
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.